← All organizations

Monopar Therapeutics

For profitWebsite ↗

Also known as: Chief Scientific Officer | Monopar Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Oct 31, 2024

Timeline

2010s

Jun 1, 2014
Monopar Therapeutics— Founded
Nov 14, 2017
Gem Pharmaceuticals— Acquired

Drugs by trial phase (14 distinct, 13 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (6 own, 2 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Gem Pharmaceuticals

Recent trials (11)

NCT06980519Lead sponsorN/A—
NCT06617169Lead sponsorPhase 1Oct 31, 2024
NCT06465472OfficialPhase 3Aug 31, 2024
NCT06451913OfficialPhase 4Jun 30, 2024
NCT06337084Lead sponsorPhase 1Apr 10, 2024
NCT05536752Overall official - principal investigatorPhase 2Sep 22, 2022
NCT05043649Lead sponsorPhase 1Sep 30, 2021
NCT04648020Lead sponsorPhase 2/Phase 3Dec 31, 2020
NCT04648020Study directorPhase 2/Phase 3Dec 31, 2020
NCT04150965OfficialPhase 1/Phase 2Dec 1, 2019
NCT04150965Overall official - principal investigatorPhase 1/Phase 2Dec 1, 2019

Details

Founded: Lake Forest, CA, US Jun 1, 2014
Last known activity: Oct 31, 2024